CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia

被引：0
|
作者：
Na Yang
Caili Zhang
Yingchun Zhang
Yuting Fan
Jing Zhang
Xiaojin Lin
Ting Guo
Yangzuo Gu
Jieheng Wu
Jianmei Gao
Xing Zhao
Zhixu He
机构：
[1] Guizhou Medical University (GMU),Tissue Engineering and Stem Cell Experiment Center
[2] Guizhou Medical University,Department of Immunology, College of Basic Medical Sciences
[3] Guizhou Medical University,Department of Biology, School of Basic Medical Sciences
[4] the Affiliated Hospital of Guizhou Medical University,Department of Gynecology
[5] Sichuan University,State Key Laboratory of Biotherapy and Cancer Center
[6] Zunyi Medical University,School of Pharmacy
[7] Chinese Academy of Medical Sciences),Key Laboratory of Adult Stem Cell Translational Research
[8] the Affiliated Hospital of Zunyi Medical University,Department of Pediatrics
来源：
Journal of Translational Medicine | / 22卷
关键词：
Chimeric antigen receptor; Natural killer cells; Dual targets; mRNA; Acute lymphoblastic leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Correlative study on the efficacy and complications of CD19 chimeric antigen receptor T cells in the treatment of recurrent/refractory acute lymphoblastic leukemia
    Wen, W.
    Xiaoling, G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1728 - 1728
  • [32] CD19 Chimeric Antigen Receptor T Cell Therapy for the Treatment of B Cell Lineage Acute Lymphoblastic Leukemia
    Chen, Runzhe
    Song, Xiao-Tong
    Chen, Baoan
    DISCOVERY MEDICINE, 2015, 20 (110) : 185 - 190
  • [33] Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
    Tu, Sanfang
    Zhou, Lijuan
    Huang, Rui
    Zhou, Xuan
    Yang, Jilong
    Li, Meifang
    Jin, Bo
    Wang, Langqi
    Zhuo, Yaqi
    Chen, Huifang
    Chang, Lung-Ji
    Li, Yuhua
    BLOOD, 2023, 142
  • [34] Functional Characterization and Optimization of Switchable Allogeneic Chimeric Antigen Receptor T Cells for Targeting CD19 and CD20 in B Cell Malignancies
    Spehr, Johannes
    Meyer, Jan-Erik
    Loff, Simon
    Langer, Anika
    Langer, Moritz
    Boyerinas, Ben
    Le Mercier, Isabelle
    Lescarbeau, Reynald
    Cartellieri, Marc
    Ehninger, Armin
    BLOOD, 2023, 142
  • [35] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Xu, Yingxi
    Lu, Yang
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [36] Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (06) : 1347 - 1356
  • [37] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Runxia Gu
    Fang Liu
    Dehui Zou
    Yingxi Xu
    Yang Lu
    Bingcheng Liu
    Wei Liu
    Xiaojuan Chen
    Kaiqi Liu
    Ye Guo
    Xiaoyuan Gong
    Rui Lv
    Xia Chen
    Chunlin Zhou
    Mengjun Zhong
    Huijun Wang
    Hui Wei
    Yingchang Mi
    Lugui Qiu
    Lulu Lv
    Min Wang
    Ying Wang
    Xiaofan Zhu
    Jianxiang Wang
    Journal of Hematology & Oncology, 13
  • [38] Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/ refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Jacoby, Elad
    Toren, Amos
    Shouval, Roni
    Itzhaki, Orit
    Avigdor, Abraham
    Shimoni, Avichai
    Nagler, Arnon
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2024, 72 (04)
  • [39] A Phase I Study of CD19 Chimeric Antigen Receptor-T Cells Generated By the PiggyBac Transposon Vector for Acute Lymphoblastic Leukemia
    Nishio, Nobuhiro
    Hanajiri, Ryo
    Ishikawa, Yuichi
    Murata, Makoto
    Taniguchi, Rieko
    Hamada, Motoharu
    Nishikawa, Eri
    Kawashima, Nozomu
    Narita, Atsushi
    Muramatsu, Hideki
    Takahashi, Yoshiyuki
    BLOOD, 2021, 138 : 3831 - +
  • [40] Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemia
    Danylesko, Ivetta
    Chowers, Guy
    Shouval, Roni
    Besser, Michal J.
    Jacoby, Elad
    Shimoni, Avichai
    Nagler, Arnon
    Avigdor, Abraham
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2020, 68 (01) : 17 - 22
12345